C11 - Neuromyelitis Optica Spectrum Disorders
| Event Time: | Saturday April 22, 2017 10:30 am to 12:30 pm |
| Topic(s): | MS and CNS Inflammatory Disease |
| Director(s): | Dean Wingerchuk MD, FAAN |
| Description: | Neuromyelitis optica spectrum disorders (NMOSD) are a collection of clinical syndromes and neuroradiological accompaniments unified by their association with an autoantibody specific for the astrocytic water channel aquaporin-4 (AQP4). Recently revised diagnostic criteria for NMOSD, which include the classic transverse myelitis and optic neuritis attacks but also define additional brain, diencephalic, and brain stem syndromes, stratify the diagnosis based on whether AQP-IgG is detected or not. Faculty will present a state-of-the-art review of NMOSD pathogenesis, diagnosis, AQP4-IgG assay interpretation, and the role of emerging autoantibodies associated with NMOSD clinical phenotypes (such as MOG-IgG) and summarize a practical approach to treatment and prevention of attacks. Case presentations will be used to illustrate key learning points during lectures and in a case-based discussion session. |
| Completion Message: | Participants should be able to understand the clinical, neuroimaging, laboratory, and pathologic characteristics of NMOSD; compare the utility of AQP4-IgG assay methods; recognize clinical characteristics associated with MOG-IgG; be able to discuss elements of the newly revised NMOSD diagnostic criteria; and describe approaches to prevention and treatment of acute NMOSD attacks. |
| CME Credits: | 2 |
| Core Competencies: | Medical Knowledge, Patient Care |
| Start/End Time | Title | Faculty |
|---|---|---|
| 10:30 AM - 11:15 AM | NMOSD: Pathogenesis and Clinical Diagnosis | Brian G. Weinshenker MD, FAAN |
| 11:15 AM - 12:00 PM | NMOSD: Current and Emerging Therapies and Strategies | Dean M. Wingerchuk MD, FAAN |
| 12:00 PM - 12:30 PM | Case-based Discussion | Faculty |
| Speaker | Disclosure |
|---|---|
| Brian G. Weinshenker, MD, FAAN | Dr. Weinshenker has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis, Alexion, MedImmune, Caladrius Biosciences and Brainstorm Therapeutics. Dr. Weinshenker has received royalty, license fees, or contractual rights payments from RSR Ltd, Oxford University, Hospices Civil de Lyon, MVZ Labor PD Dr. Volkmann und Kollegen GbR. |
| Dean M. Wingerchuk, MD, FAAN | Dr. Wingerchuk has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Caladrius and MedImmune. Dr. Wingerchuk has received personal compensation in an editorial capacity for The Neurologist. Dr. Wingerchuk has received research support from Alexion and TerumoBCT. |
Ready to register for the 2018 AAN Annual Meeting?
Related Courses
| 9:30 AM-11:30 AM | ||
|---|---|---|
| C11 | Treatment of Pediatric Multiple Sclerosis in the Current Era | Brenda Banwell MD, FAAN |
| 10:15 AM-10:45 AM | ||
| Collaboration Corner: Wellness Break | Lucy Persaud Samaroo | |
| 3:30 PM-4:00 PM | ||
| Collaboration Corner: Wellness Break | Lucy Persaud Samaroo | |
| 4:15 PM-5:30 PM | ||
| PL1 | Hot Topics Plenary Session | |
| 7:00 AM-9:00 AM | ||
|---|---|---|
| C34 | Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making | Aaron Miller MD, FAAN |
| 9:30 AM-10:00 AM | ||
| Collaboration Corner: Medical Student Office Hours | Rana Said MD | |
| 11:30 AM-5:30 PM | ||
| P1 | Poster Session I | |
| 1:00 PM-3:00 PM | ||
| S6 | MS Neuroimaging | |
| 2:30 PM-3:00 PM | ||
| Innovations for Multiple Sclerosis Monitoring and Care | Tanuja Chitnis MD, FAAN | |
| 3:30 PM-4:30 PM | ||
| Collaboration Corner: Wellness Break | Lucy Persaud Samaroo | |
| 3:30 PM-5:30 PM | ||
| C59 | Actualización Sobre el Tratamiento de la Esclerosis Múltiple | Lilyana Amezcua MD |
| S8 | Progressive MS Therapies and Age-Dependent Factors in MS Therapy | |
| 4:00 PM-4:30 PM | ||
| Transitioning from Private Practice to Academics | Neil Busis MD, FAAN | |
| 9:15 AM-11:30 AM | ||
|---|---|---|
| PL3 | Contemporary Clinical Issues Plenary Session | |
| 11:30 AM-7:00 PM | ||
| P2 | Poster Session II | |
| 1:00 PM-3:00 PM | ||
| C74 | Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I | Jeffrey Gelfand MD, MAS, FAAN |
| S13 | Neuromyelitis Optica Spectrum Disorder and other Autoimmune Disorders | |
| 1:30 PM-2:15 PM | ||
| Collaboration Corner: Wellness Break | Lucy Persaud Samaroo | |
| 3:30 PM-5:30 PM | ||
| C87 | Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II | Jeffrey Gelfand MD, MAS, FAAN |
| C95 | Actualización Sobre las Infecciones del Sistema Nervioso Central y la Medicina Tropical | Oscar Del Brutto MD, FAAN |
| 4:00 PM-4:30 PM | ||
| Panel Discussion with the 2018 John Dystel Prize for Multiple Sclerosis Research Award Recipient | Nancy Sicotte MD, FAAN, Frederik Barkhof |
|
| 7:00 AM-9:00 AM | ||
|---|---|---|
| C98 | Multiple Sclerosis Overview I: Clinical Pearls | John Corboy MD, FAAN |
| 9:15 AM-11:30 AM | ||
| PL4 | Clinical Trials Plenary Session | |
| 10:15 AM-10:45 AM | ||
| Collaboration Corner: Wellness Break | Lucy Persaud Samaroo | |
| 11:30 AM-7:00 PM | ||
| P3 | Poster Session III | |
| 12:00 PM-12:45 PM | ||
| Collaboration Corner: Medical Student Office Hours | Justin Jordan MD, MPH | |
| 1:00 PM-3:00 PM | ||
| C109 | Multiple Sclerosis Overview II: Clinical Advances | Scott Newsome DO, FAAN |
| 1:30 PM-2:15 PM | ||
| Collaboration Corner: Wellness Break | Lucy Persaud Samaroo | |
| 3:30 PM-5:30 PM | ||
| C122 | Multiple Sclerosis Overview III: The Pathogenesis of Multiple Sclerosis and Mechanism of Action of Treatments for MS | Olaf Stuve MD, PhD, FAAN |
| S24 | MS Outcome Measures and Biomarkers | |
| 4:45 PM-5:15 PM | ||
| Residents and Fellows Office Hours | Sahil Gupta MD, Abhimanyu Mahajan MD |
|
| 7:00 AM-9:00 AM | ||
|---|---|---|
| C175 | Clinical Pearls in Autoimmune Neurology: Real World Cases | Stacey Clardy MD, PhD |
| 10:15 AM-10:45 AM | ||
| Collaboration Corner: Wellness Break | Lucy Persaud Samaroo | |
| 11:30 AM-7:00 PM | ||
| P5 | Poster Session V | |
| 11:45 AM-12:35 PM | ||
| PD5 | MS and CNS Inflammatory Disease Poster Discussion Session | |
| 1:00 PM-3:00 PM | ||
| N5 | Neuroscience in the Clinic: Treatment of Progressive Multiple Sclerosis | Eric Klawiter MD, FAAN, Ellen Mowry MD, FAAN |
| 2:00 PM-3:00 PM | ||
| Using your Patients as Resources: Group Medical Visits for Improved Wellness and Efficiency | Mary Rensel MD, FAAN, Nancy Isenberg MD, MPH, FAAN |
|
| 3:30 PM-4:00 PM | ||
| Collaboration Corner: Wellness Break | Lucy Persaud Samaroo | |
| 3:30 PM-5:30 PM | ||
| C199 | Neurology Update IV: Multiple Sclerosis, Neuro-ophthalmology, and Autoimmune Encephalopathies | Adam Quick MD |
| S44 | MS Risk Factors, Susceptibility, Diagnosis, and Cognitive Impairment | |
| 8:00 AM-9:00 AM | ||
|---|---|---|
| S47 | "Best of" Session: MS and CNS Inflammatory Diseases | |
| 10:15 AM-10:45 AM | ||
| Collaboration Corner: Wellness Break | Lucy Persaud Samaroo | |
| 11:30 AM-5:30 PM | ||
| P6 | Poster Session VI | |
| 1:00 PM-3:00 PM | ||
| C224 | Neuromyelitis Optica Spectrum Disorders | Dean Wingerchuk MD, FAAN |
| S51 | Pediatric MS | |
| 3:30 PM-4:00 PM | ||
| Collaboration Corner: Wellness Break | Lucy Persaud Samaroo | |
| 3:30 PM-5:30 PM | ||
| S52 | MS and CNS Inflammatory Disease: Basic Science | |
| 4:30 PM-5:30 PM | ||
| Ask the Expert: Discussion on Multiple Sclerosis | John Corboy MD, FAAN, Brian Weinshenker MD, FAAN, Barbara Giesser MD, FAAN |
|